Towards an earlier diagnosis of Alzheimer disease (proceedings of the 5th MCI symposium, 2007)

Lisa J. Bain, Warren Barker, David Loewenstein, Ranjan Duara

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The 5th annual Mild Cognitive Impairment Symposium, held on April 13th and 14th, 2007, in Miami Beach, Florida, focused on the question of whether the time has come to revise criteria for Alzheimer disease (AD). The symposium, sponsored by the Wien Center for Alzheimer's Disease and Memory Disorders, Mt Sinai Medical Center in Miami Beach, Florida; and the Byrd Alzheimer Center and Research Institute in Tampa, Florida, brought together an international group of clinicians and researchers to examine current evidence for developing new criteria for AD and for outlining areas that still require clarification. Neuropathologic, neuroimaging, epi-demiologic, and clinical perspectives were presented and discussed, as well as the impact of ethnic and cultural differences. As became evident, each perspective introduces different challenges in terms of selecting the appropriate assessment tools; determining when, where, and by whom the diagnosis should be given; and deciding whether multiple sets of criteria are needed for use in different settings, for example, research versus primary care practices. As was intended, the symposium delivered no consensus; however, there was substantial support for the idea that AD can and probably should be diagnosed before the onset of dementia, particularly as new interventions become available.

Original languageEnglish
Pages (from-to)99-110
Number of pages12
JournalAlzheimer Disease and Associated Disorders
Volume22
Issue number2
DOIs
StatePublished - Apr 1 2008

Fingerprint

Early Diagnosis
Alzheimer Disease
Memory Disorders
Neuroimaging
Dementia
Primary Health Care
Consensus
Research Personnel
Research

Keywords

  • Biomarkers
  • Dementia
  • Informant interviews
  • Mild cognitive impairment
  • Neuroimaging
  • Prodromal Alzheimer disease

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Gerontology
  • Clinical Psychology
  • Neuroscience(all)

Cite this

Towards an earlier diagnosis of Alzheimer disease (proceedings of the 5th MCI symposium, 2007). / Bain, Lisa J.; Barker, Warren; Loewenstein, David; Duara, Ranjan.

In: Alzheimer Disease and Associated Disorders, Vol. 22, No. 2, 01.04.2008, p. 99-110.

Research output: Contribution to journalArticle

@article{5c889bfc22d240c0a9a5a31686f4d7ac,
title = "Towards an earlier diagnosis of Alzheimer disease (proceedings of the 5th MCI symposium, 2007)",
abstract = "The 5th annual Mild Cognitive Impairment Symposium, held on April 13th and 14th, 2007, in Miami Beach, Florida, focused on the question of whether the time has come to revise criteria for Alzheimer disease (AD). The symposium, sponsored by the Wien Center for Alzheimer's Disease and Memory Disorders, Mt Sinai Medical Center in Miami Beach, Florida; and the Byrd Alzheimer Center and Research Institute in Tampa, Florida, brought together an international group of clinicians and researchers to examine current evidence for developing new criteria for AD and for outlining areas that still require clarification. Neuropathologic, neuroimaging, epi-demiologic, and clinical perspectives were presented and discussed, as well as the impact of ethnic and cultural differences. As became evident, each perspective introduces different challenges in terms of selecting the appropriate assessment tools; determining when, where, and by whom the diagnosis should be given; and deciding whether multiple sets of criteria are needed for use in different settings, for example, research versus primary care practices. As was intended, the symposium delivered no consensus; however, there was substantial support for the idea that AD can and probably should be diagnosed before the onset of dementia, particularly as new interventions become available.",
keywords = "Biomarkers, Dementia, Informant interviews, Mild cognitive impairment, Neuroimaging, Prodromal Alzheimer disease",
author = "Bain, {Lisa J.} and Warren Barker and David Loewenstein and Ranjan Duara",
year = "2008",
month = "4",
day = "1",
doi = "10.1097/WAD.0b013e3181630b93",
language = "English",
volume = "22",
pages = "99--110",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Towards an earlier diagnosis of Alzheimer disease (proceedings of the 5th MCI symposium, 2007)

AU - Bain, Lisa J.

AU - Barker, Warren

AU - Loewenstein, David

AU - Duara, Ranjan

PY - 2008/4/1

Y1 - 2008/4/1

N2 - The 5th annual Mild Cognitive Impairment Symposium, held on April 13th and 14th, 2007, in Miami Beach, Florida, focused on the question of whether the time has come to revise criteria for Alzheimer disease (AD). The symposium, sponsored by the Wien Center for Alzheimer's Disease and Memory Disorders, Mt Sinai Medical Center in Miami Beach, Florida; and the Byrd Alzheimer Center and Research Institute in Tampa, Florida, brought together an international group of clinicians and researchers to examine current evidence for developing new criteria for AD and for outlining areas that still require clarification. Neuropathologic, neuroimaging, epi-demiologic, and clinical perspectives were presented and discussed, as well as the impact of ethnic and cultural differences. As became evident, each perspective introduces different challenges in terms of selecting the appropriate assessment tools; determining when, where, and by whom the diagnosis should be given; and deciding whether multiple sets of criteria are needed for use in different settings, for example, research versus primary care practices. As was intended, the symposium delivered no consensus; however, there was substantial support for the idea that AD can and probably should be diagnosed before the onset of dementia, particularly as new interventions become available.

AB - The 5th annual Mild Cognitive Impairment Symposium, held on April 13th and 14th, 2007, in Miami Beach, Florida, focused on the question of whether the time has come to revise criteria for Alzheimer disease (AD). The symposium, sponsored by the Wien Center for Alzheimer's Disease and Memory Disorders, Mt Sinai Medical Center in Miami Beach, Florida; and the Byrd Alzheimer Center and Research Institute in Tampa, Florida, brought together an international group of clinicians and researchers to examine current evidence for developing new criteria for AD and for outlining areas that still require clarification. Neuropathologic, neuroimaging, epi-demiologic, and clinical perspectives were presented and discussed, as well as the impact of ethnic and cultural differences. As became evident, each perspective introduces different challenges in terms of selecting the appropriate assessment tools; determining when, where, and by whom the diagnosis should be given; and deciding whether multiple sets of criteria are needed for use in different settings, for example, research versus primary care practices. As was intended, the symposium delivered no consensus; however, there was substantial support for the idea that AD can and probably should be diagnosed before the onset of dementia, particularly as new interventions become available.

KW - Biomarkers

KW - Dementia

KW - Informant interviews

KW - Mild cognitive impairment

KW - Neuroimaging

KW - Prodromal Alzheimer disease

UR - http://www.scopus.com/inward/record.url?scp=46249089558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249089558&partnerID=8YFLogxK

U2 - 10.1097/WAD.0b013e3181630b93

DO - 10.1097/WAD.0b013e3181630b93

M3 - Article

C2 - 18525280

AN - SCOPUS:46249089558

VL - 22

SP - 99

EP - 110

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - 2

ER -